According to DelveInsight’s analysis, the mild cognitive impairment market is anticipated to increase during the forecast period (2024–2034), owing to the rise in the launch of emerging therapies and healthcare spending globally. LAS VEGAS, Jan. 8, 2025 /PRNewswire/ — DelveInsight’s Mild…